Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new version of the page’s documentation. This reflects an internal update to the page’s revision history rather than a substantive alteration to study details.
    Difference
    0.0%
    Check dated 2026-07-28T12:27:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3, signaling a newer page revision. This update appears to be a maintenance/format change rather than a modification to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-30T01:16:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited and adds new sections to help readers read the study record, understand common questions, and learn how to join the study. It also includes a minor formatting change to the Intervention/Treatment label and updates the revision note to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T18:20:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.5) in the footer, replacing the previous v3.5.4. This indicates a minor internal update to the page rendering or maintenance.
    Difference
    0.0%
    Check dated 2026-06-08T14:54:06.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.4' was added. It replaces the previous 'Revision: v3.5.3' to reflect the latest release.
    Difference
    0.0%
    Check dated 2026-05-18T03:57:29.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, indicating an interface or documentation build change rather than an update to the underlying trial study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:24:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.